Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
Zhidong Hu, Shuihua Lu, Douglas B. Lowrie, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
Zhuang Li, Ling Yang, Linsheng Li, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 20
Key advances in vaccine development for tuberculosis—success and challenges
Rocky Lai, Abiola F. Ogunsola, Tasfia Rakib, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines
Prasad D. Trivedi, Barry J. Byrne, Manuela Corti
Viruses (2023) Vol. 15, Iss. 12, pp. 2378-2378
Open Access | Times Cited: 23
Immune correlates of protection as a game changer in tuberculosis vaccine development
Jing Wang, Xiao‐Yong Fan, Zhidong Hu
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles
Ikhazuagbe H. Ifijen, Best Atoe, Raphael O. Ekun, et al.
BioNanoScience (2023) Vol. 13, Iss. 1, pp. 249-277
Open Access | Times Cited: 20
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
Fangbin Zhou, Dongmei Zhang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis
Zhidong Hu, Jing-xian Xia, Juan Wu, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Vaccine development against tuberculosis before and after Covid-19
Stefan H. E. Kaufmann
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Advances in understanding immune homeostasis in latent tuberculosis infection
Liangfei Niu, Hao Wang, Geyang Luo, et al.
WIREs Mechanisms of Disease (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 4
Tuberculosis Vaccines and T Cell Immune Memory
Fei Li, Wenrui Dang, Yunjie Du, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 483-483
Open Access | Times Cited: 4
The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges
Rosy Ghanem, Raphaëlle Youf, Tanguy Haute, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 421-439
Open Access
Recent gene therapy approaches for the treatment of tuberculosis
Nimisha Srivastava, Emamezi Samuel
Elsevier eBooks (2025), pp. 195-204
Closed Access
Tuberculosis vaccines: advancements and on-going clinical trials
H Surendran, S. Swathi Krishna, M.S. Sudheesh
Elsevier eBooks (2025), pp. 339-352
Closed Access
Machine Learning Prediction of Mycobacterial Cell Wall Permeability of Drugs and Drug-like Compounds
Eugene V. Radchenko, Grigory V. Antonyan, Stanislav K. Ignatov, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 633-633
Open Access | Times Cited: 9
Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines
Hongmin Kim, Han‐Gyu Choi, Sung Jae Shin
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
Wenping Gong, Jingli Du
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 224-226
Open Access | Times Cited: 8
Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring
Xiaofei Peng, Yuting Zhou, Baoying Zhang, et al.
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105518-105518
Open Access | Times Cited: 8
Antibodies as clinical tools for tuberculosis
Sophie McIntyre, Jeffrey Warner, C. M. Rush, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies
Hui Wang, Shuxian Wang, Fang Ren, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 38-38
Open Access | Times Cited: 7
Editorial: Innate and adaptive immunity against tuberculosis infection: diagnostics, vaccines, and therapeutics
Zhidong Hu, Lanbo Shi, Jianping Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention
Sergio Lacámara, Carlos Martı́n
Archivos de Bronconeumología (2023) Vol. 59, Iss. 12, pp. 821-828
Open Access | Times Cited: 5
The Induction of Antigen 85B-Specific CD8+ T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice
Shihoko Komine‐Aizawa, Satoru Mizuno, Akira Kawano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 966-966
Open Access | Times Cited: 4
A modular self-assembling and self-adjuvanting multiepitope peptide nanoparticle vaccine platform to improve the efficacy and immunogenicity of BCG
Guangzu Zhao, Harindra D. Sathkumara, Socorro Miranda‐Hernandez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
Dulce Mata‐Espinosa, Jacqueline V. Lara-Espinosa, Jorge Barrios‐Payán, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1475-1475
Open Access | Times Cited: 3
Nano-Sized Chimeric Human Papillomavirus-16 L1 Virus-like Particles Displaying Mycobacterium tuberculosis Antigen Ag85B Enhance Ag85B-Specific Immune Responses in Female C57BL/c Mice
Fangbin Zhou, Dongmei Zhang
Viruses (2023) Vol. 15, Iss. 10, pp. 2123-2123
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top